Aristo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.90 M
- Paid Up Capital ₹ 9.90 M
- Company Age 53 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.61 Cr
- Revenue Growth 6.55%
- Profit Growth 0.79%
- Ebitda 2.86%
- Net Worth 19.02%
- Total Assets 17.81%
About Aristo Pharmaceuticals
Aristo Pharmaceuticals Private Limited (APPL) was founded in India on 08 November 1971 and has a glorious history of 53 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Aristo Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.90 M and a paid-up capital of Rs 9.90 M.
The company has closed loans amounting to ₹7.61 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Randhir Bachan, Umesh Sharma, and Virendra Sharma serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239MH1971PTC015425
-
Company No.
015425
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Nov 1971
-
Date of AGM
04 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Aristo Pharmaceuticals Private Limited offer?
Aristo Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Diabetes Medicine, Anti Infective Drugs & Medicines, HIV Drugs, Common Disease Medicines, Pharmaceutical Tablets.
Who are the key members and board of directors at Aristo Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Sharma
|
Managing Director | 12-Feb-1979 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Randhir Bachan
|
Whole-Time Director | 01-Sep-2005 | Current |
|
Virendra Sharma
|
Director | 03-Oct-2006 | Current |
Financial Performance of Aristo Pharmaceuticals.
Aristo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.55% increase. The company also saw a slight improvement in profitability, with a 0.79% increase in profit. The company's net worth Soared by an impressive increase of 19.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aristo Pharmaceuticals?
In 2023, Aristo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mapra Laboratories Pvt LtdRandhir Bachan is a mutual person
-
Aristo Laboratories Private LimitedUmesh Sharma and Virendra Sharma are mutual person
-
Rosewell Pharmaceuticals Private Limited
Umesh Sharma is a mutual person
-
Nobel Enkem Private Limited
Virendra Sharma is a mutual person
Charges (Loans)
₹0
₹76.07 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.05 Cr
- Bank Of India : 1.00 Cr
- Srate Bank Of India : 1.00 Cr
- Bank Of India : 0.40 Cr
- State Industrial & Investment Corporation : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 1993 | Srate Bank Of India | ₹1.00 Cr | Satisfied |
| 08 Aug 1988 | State Bank Of India | ₹5.05 Cr | Satisfied |
| 11 Dec 1980 | Bank Of India | ₹4.00 M | Satisfied |
| 14 Nov 1980 | Bank Of India | ₹4.00 M | Satisfied |
| 10 Mar 1979 | Bank Of India | ₹5.30 M | Satisfied |
How Many Employees Work at Aristo Pharmaceuticals?
Aristo Pharmaceuticals has a workforce of 9056 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aristo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aristo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
